NeOnc Technologies Holdings (NASDAQ:NTHI) is approaching an important two-week period, with additional CEO share purchases, renewed analyst support and two upcoming clinical milestones bringing the small-cap biotechnology company back into focus.

WSW, NY, November 9th, 2026, FinanceWire

Edesa Biotech (NASDAQ:EDSA) secured a Japanese pharmaceutical partner for paridiprubart, its experimental treatment for acute respiratory distress syndrome (ARDS), in a licensing agreement that could generate more than $146 million in upfront and milestone payments, plus royalties.

AMTD is reshuffling of assets within its own corporate group. The company has transferred interests in four hotels in New York, London, Perth and Kuala Lumpur into The Generation Essentials Group (NYSE:TGE), assigning them an aggregate value of US$209.8 million. Completed on November 2 and announced on November 6, the transaction moves the interests from AMTD Digital (NYSE:HKD) into TGE, another company controlled by the AMTD IDEA Group (NYSE:AMTD). In exchange, TGE issued 198,630,381 new Class A shares to AMTD Digital. No cash purchase payment was involved.